REGENXBIO Inc.
RGNX
$12.59
$0.383.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 39.21% | -76.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 39.21% | -76.00% | |||
| Cost of Revenue | -4.46% | 14.48% | |||
| Gross Profit | 25.97% | -233.43% | |||
| SG&A Expenses | 1.86% | -2.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 44.44% | 200.00% | |||
| Total Operating Expenses | -2.95% | 10.08% | |||
| Operating Income | 17.17% | -621.79% | |||
| Income Before Tax | 12.60% | -1,265.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 12.60% | -1,265.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.60% | -1,265.07% | |||
| EBIT | 17.17% | -621.79% | |||
| EBITDA | 18.27% | -469.19% | |||
| EPS Basic | 12.95% | -1,262.67% | |||
| Normalized Basic EPS | 12.95% | -1,262.70% | |||
| EPS Diluted | 12.95% | -1,262.67% | |||
| Normalized Diluted EPS | 12.95% | -1,264.28% | |||
| Average Basic Shares Outstanding | 0.40% | 0.24% | |||
| Average Diluted Shares Outstanding | 0.40% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||